Literature DB >> 16174837

Hepatocellular enzyme elevations in a patient receiving ceftriaxone.

Anastasia M Rivkin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16174837     DOI： 10.2146/ajhp040452

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  3 in total

1.  Synthesis, Spectroscopic Studies for Five New Mg (II), Fe (III), Cu (II), Zn (II) and Se (IV) Ceftriaxone Antibiotic Drug Complexes and Their Possible Hepatoprotective and Antioxidant Capacities.

Authors:  Samy M El-Megharbel; Safa H Qahl; Fatima S Alaryani; Reham Z Hamza
Journal:  Antibiotics (Basel)       Date:  2022-04-20

Review 2.  Adverse reaction to ceftriaxone in a 28-day-old infant undergoing urgent craniotomy due to epidural hematoma: review of neonatal biliary pseudolithiasis.

Authors:  Alicja Bartkowska-Śniatkowska; Katarzyna Jończyk-Potoczna; Marzena Zielińska; Jowita Rosada-Kurasińska
Journal:  Ther Clin Risk Manag       Date:  2015-07-02       Impact factor: 2.423

3.  Rapid Onset of Ceftriaxone-Induced Cholelithiasis in an Adult Patient.

Authors:  Hani Abdelaziz; Nancy Cormier; Tania Levesque; Jean St-Yves; Muhanad Al Habash; Oscar Diaz; Marie-Pierre Haberer; Dariu Calugaroiu; Mohamed Nashed
Journal:  J Glob Infect Dis       Date:  2022-02-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.